Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1197-1203

  Castagnola, E ^a   Furfaro, E ^b   Caviglia, I ^a   Licciardello, M ^c   Faraci, M ^a   Fioredda, F ^a   Toma P ^a   Bandettini, R ^a   Machetti, M ^d   Viscoli, C ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Advanced Biotechnology Centre   (Italy)

Author keywords

Cancer; Galactomannan antigen; Haemopoietic stem cell transplantation; Invasive aspergillosis; Leukaemia; Paediatrics

Indexed keywords

GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM; MANNAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INFANT; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NONLYMPHATIC LEUKEMIA; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; ASPERGILLOSIS; BLOOD; COMPLICATION; EVALUATION STUDY; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; MYCOLOGY; NEOPLASM; PREDICTIVE VALUE; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOASSAY; IMMUNOCOMPROMISED HOST; INFANT; MANNANS; MYCOLOGY; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; YOUNG ADULT;

EID: 77952003525     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03065.x     Document Type: Article

References (35)

1. Hovi L, Saarinen-Pihkala U, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000, 26:999-1004.
2. Benjamin DKJ, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002, 21:227-234.
3. Castagnola E, Fontana V, Caviglia I. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007, 45:1296-1304.
4. Burgos A, Zaoutis TE, Dvorak CC. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008, 121:e1286-e1294.
5. Abbasi S, Shenep J, Hughes W, Flynn P. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999, 29:1210-1219.
6. Barker JN, Hough RE, van Burik JA. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005, 11:362-370.
7. Castagnola E, Cesaro S, Giacchino M. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 2006, 25:634-639.
8. Dvorak C, Steinbach W, Brown J, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005, 36:621-629.
9. Groll A, Kurz M, Schneider W. Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 1999, 42:431-442.
10. Rosen G, Nielsen K, Glenn S, Abelson J, Deville J, Moore T. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol 2005, 27:135-140.
11. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial aml-bfm 93. Leukemia 2004, 18:72-77.
12. Castagnola E, Bagnasco F, Faraci M. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 2008, 41:339-347.
13. Castagnola E, Faraci M, Moroni C. Invasive mycoses in children receiving hemopoietic sct. Bone Marrow Transplant 2008, 41:S107-S111.
14. Ascioglu S, Rex JH, de Pauw B. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
15. De Pauw B, Walsh TJ, Donnelly JP. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008, 46:1813-1821.
16. Herbrecht R, Letscher-Bru V, Oprea C. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002, 20:898-906.
17. Steinbach WJ, Addison RM, McLaughlin L. Prospective aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007, 26:558-564.
18. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001, 91:311-318.
19. De Pauw B, Verveij PE. Infections in patients with hematologic malignancies. Principles and practice of infectious diseases 2005, 3432-3441. Mandell GL, Bennett JEDoolin R. In, eds, Philadelphia, PA, Churchill Livingstone
20. van Burik J, Weisdorf D. Infections in recipients of hematopoietic stem cell transplantation. Principles and practice of infectious diseases 2005, 3486-3501. Mandell GL, Bennett JEDoolin R. In, eds, Philadelphia, PA, Churchill Livingstone
21. Maertens J, Theunissen K, Verbeken E. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004, 126:852-860.
22. Viscoli C, Castagnola E. Prophylaxis and empirical therapy for infection in cancer patients. Principles and practice of infectious diseases 2005, 3442-3462. Mandell GL, Bennett JEDoolin R. In, eds, Philadelphia, PA, Churchill Livingstone
23. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427.
24. Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 2000, 30:127-134.
25. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA 1994, 271:703-707.
26. Zenilman JM, Miller WC, Gaydos C, Rogers SM, Turner CF. LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value. Sex Transm Infect 2003, 79:94-97.
27. Castagnola E, Caviglia I, Pistorio A. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 2005, 41:1439-1445.
28. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer 2001, 37:2413-2419.
29. Hovi L, Saxen H, Saarinen-Pihkala U, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 2007, 48:28-34.
30. Castagnola E, Viscoli C. Invasive aspergillosis in malignancy and stem cell transplant recipients. Aspergillus fumigatus and aspergillosis 2009, 519-530. Legté JP, Steinbach WJ. In, eds, Washington, DC, American Society for Microbiology
31. Hamaki T, Kami M, Kanda Y. False-positive results of aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001, 28:633-634.
32. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002, 186:1297-1306.
33. Ansorg R, van den Boom R, Rath PM. Detection of aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997, 40:353-357.
34. Gangneux JP, Lavarde D, Bretagne S, Guiguen C, Gandemer V. Transient aspergillus antigenaemia: think of milk. Lancet 2002, 359:1251.
35. Faraci M, Dallorso S, Morreale G. Surgery for acute graft-versus-host disease of the bowel: description of a pediatric case. J Pediatr Hematol Oncol 2004, 26:441-443.